Latest Articles
Organon halts development of endometriosis pain drug after trial failure By Investing.com - Investing.com Nigeria
Organon halts development of endometriosis pain drug after trial failure By Investing.com Investing.com Nigeria
Published: July 2, 2025, 12:52 p.m.
Organon Provides Update on Phase 2 ELENA Proof-Of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain - MarketScreener
Organon Provides Update on Phase 2 ELENA Proof-Of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain MarketScreener
Published: July 2, 2025, 12:51 p.m.
Organon's OG-6219 Failure: A Crossroads for Women's Health Innovation and Financial Strategy - AInvest
Organon's OG-6219 Failure: A Crossroads for Women's Health Innovation and Financial Strategy AInvest
Published: July 2, 2025, 12:47 p.m.
Organon axes 'biggest potential opportunity' after flunking phase 2 trial - Fierce Biotech
Organon axes 'biggest potential opportunity' after flunking phase 2 trial Fierce Biotech
Published: July 2, 2025, 12:43 p.m.
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint - MarketScreener
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint MarketScreener
Published: July 2, 2025, 12:10 p.m.
Organon halts development of endometriosis pain drug after trial failure By Investing.com - Investing.com Canada
Organon halts development of endometriosis pain drug after trial failure By Investing.com Investing.com Canada
Published: July 2, 2025, 12:08 p.m.
Organon ELENA trial misses primary endpoint, to discontinue OG-6219 program - TipRanks
Organon ELENA trial misses primary endpoint, to discontinue OG-6219 program TipRanks
Published: July 2, 2025, 11:54 a.m.
Organon to halt development of endometriosis pain drug after mid-stage trial failure - MarketScreener
Organon to halt development of endometriosis pain drug after mid-stage trial failure MarketScreener
Published: July 2, 2025, 11:52 a.m.
Organon abandons endometriosis pain drug development after trial failure - MarketScreener
Organon abandons endometriosis pain drug development after trial failure MarketScreener
Published: July 2, 2025, 11:52 a.m.
Organon halts development of endometriosis pain drug after trial failure - Investing.com
Organon halts development of endometriosis pain drug after trial failure Investing.com
Published: July 2, 2025, 11:42 a.m.
Link copied to clipboard!